Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites

Jeremy Carlier1, Xingxing Diao1,2, Karl B Scheidweiler1

  • 1Chemistry & Drug Metabolism Section, Clinical Pharmacology & Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD.

Clinical Chemistry
|March 18, 2017
PubMed
Abstract

Related Concept Videos